Submitted by Anonymous (not verified) on 26 February 2026 - 11:05
Human medicines European public assessment report (EPAR): Revolade, eltrombopag, Date of authorisation: 11/03/2010, Revision: 39, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Revolade, eltrombopag, Date of authorisation: 11/03/2010, Revision: 39, Status: Authorised